Ergomed (ERGO)

 

Latest News

Ergomed notes partner's successful financing round

Ergomed has noted that its co-development partner Modus Therapeutics has announced a successful financing round, rais...

Modus Therapeutics Raises SEK 32 Million

RNS Number: 2443X Ergomed plc 20 February 2017 PRESS RELEASE FOR IMMEDIATE RELEASE Ergomed notes co-development partner Modus Therapeutics successfully raises SEK 32 million (2.9m) London, UK - 20 February 2017: Ergomed plc (LSE: ERGO) ('Ergomed' or 'the Company'), a company dedicated to the provision of specialised services to the phar...

Broker Forecast - Numis issues a broker note on Ergomed Plc

Numis today reaffirms its buy investment rating on Ergomed Plc (LON:ERGO) and set its price target at 277p.

Broker Forecast - Stifel issues a broker note on Ergomed Plc

Stifel today reaffirms its buy investment rating on Ergomed Plc (LON:ERGO) and raised its price target to 315p (from 300...

All News

DateHeadlineSource
20-02-17Ergomed notes partner's successful financing roundStockMarketWire
20-02-17Modus Therapeutics Raises SEK 32 MillionRNS
06-02-17Broker Forecast - Numis issues a broker note on Ergomed PlcStockMarketWire
06-02-17Broker Forecast - Stifel issues a broker note on Ergomed PlcStockMarketWire
06-02-17Positive Phase II top-line results of LorediplonRNS
03-02-17Broker Forecast - N+1 Singer issues a broker note on Ergomed PlcStockMarketWire
31-01-17Completion of ZoptrexT Phase 3 Clinical TrialRNS
17-01-1725 momentum stocks for 2017Interactive Investor
17-01-17Ergomed revenues up 26%StockMarketWire
17-01-17Trading StatementRNS
01-12-16Ergomed CFO and general counsel granted optionsStockMarketWire
30-11-16Award of Options by CEO to CFO and General CounselRNS
29-11-16Acquisition of PharmInventRNS
21-11-16Ergomed chairman to step down StockMarketWire
21-11-16Proposed Board ChangesRNS
16-11-16Ergomed expands clinical study with Modus TherapeuticsStockMarketWire
16-11-16Research Update from Modus TherapeuticsRNS
15-11-16Holding(s) in CompanyRNS
07-11-16Broker Forecast - N+1 Singer issues a broker note on Ergomed PlcStockMarketWire
01-11-16Co-Development Agreement with Asarina ABRNS
24-10-16Ergomed notes Dilaforette's plans for IPO StockMarketWire
24-10-16Ergomed notes news from co-development partnerRNS
21-10-16Broker Forecast - N+1 Singer issues a broker note on Ergomed PlcStockMarketWire
14-10-16Fourth licensing agreement for ZoptrexRNS
26-09-16Ergomed revenues up StockMarketWire
26-09-16Half-year ReportRNS
22-09-16Ergomed contract win StockMarketWire
22-09-16Contract win validates rationale of acquisitionsRNS
16-09-16Ergomed receives a "buy" recommendationRNS
08-09-16Ergomed completes clinical trial recruitment StockMarketWire
08-09-16Recruitment completed in phase IIa clinical trialRNS
07-09-16Notice of ResultsRNS
02-09-16Broker Forecast - Stifel issues a broker note on Ergomed PlcStockMarketWire
02-09-16Ergomed co-development partner licensing deals StockMarketWire
02-09-16Co-development partner announces licensing dealsRNS
15-08-16Change of Nominated AdviserRNS
15-08-16Disclosure of Directors' AppointmentsRNS
27-06-16Ergomed resolutions passed at AGMStockMarketWire
27-06-16Result of AGMRNS
27-06-16Ergomed Plc to present at the SHARES Investor Evening in London on 30th June.StockMarketWire

RSS feeds

  • Editorial news feed for LSE:ERGO Editorial
  • Regulatory news feed for LSE:ERGO Regulatory